For: | Sinagra E, Utzeri E, Morreale GC, Fabbri C, Pace F, Anderloni A. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians. World J Clin Cases 2020; 8(6): 1013-1025 [PMID: 32258072 DOI: 10.12998/wjcc.v8.i6.1013] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i6/1013.htm |
Number | Citing Articles |
1 |
Yaser Zandeh-Rahimi, Negar Panahi, Saeed Hesaraki, Seyed Hamed Shirazi-Beheshtiha. Protective Effects of Phoenixin-14 Peptide in the Indomethacin-Induced Duodenal Ulcer: An Experimental Study. International Journal of Peptide Research and Therapeutics 2022; 28(1) doi: 10.1007/s10989-021-10314-9
|
2 |
Anna Onisiforou, George M. Spyrou. Immunomodulatory effects of microbiota-derived metabolites at the crossroad of neurodegenerative diseases and viral infection: network-based bioinformatics insights. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.843128
|
3 |
Feng Zhao, Suzhen Guan, Youjuan Fu, Kai Wang, Zhihong Liu, Tzi Bun Ng. Lycium barbarum polysaccharide attenuates emotional injury of offspring elicited by prenatal chronic stress in rats via regulation of gut microbiota. Biomedicine & Pharmacotherapy 2021; 143: 112087 doi: 10.1016/j.biopha.2021.112087
|
4 |
Caterina Carco, Wayne Young, Richard B. Gearry, Nicholas J. Talley, Warren C. McNabb, Nicole C. Roy. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00468
|
5 |
İrem Nur ŞAHİN. Gut-Beyin Ekseni, Nörodejeneratif Hastalıklar Ve Mikrobiyatanın Etkileri. İstanbul Sabahattin Zaim Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2022; 4(2): 80 doi: 10.47769/izufbed.1083687
|
6 |
Emily M. Borsom, Kathryn Conn, Christopher R. Keefe, Chloe Herman, Gabrielle M. Orsini, Allyson H. Hirsch, Melanie Palma Avila, George Testo, Sierra A. Jaramillo, Evan Bolyen, Keehoon Lee, J. Gregory Caporaso, Emily K. Cope, Jennifer M. Auchtung. Predicting Neurodegenerative Disease Using Prepathology Gut Microbiota Composition: a Longitudinal Study in Mice Modeling Alzheimer’s Disease Pathologies. Microbiology Spectrum 2023; 11(2) doi: 10.1128/spectrum.03458-22
|
7 |
Simranjit Kaur, Arshdeep Singh, Harpreet Kaur, Jagbir Singh, Rajbir Bhatti. Advanced Drug Delivery Systems for Colonic Disorders. 2024; : 23 doi: 10.1016/B978-0-443-14044-0.00007-7
|
8 |
Darko Dimitrovski, Maja Dimitrovska‐Vetadjoka, Hristo Hristov, Donka Doneva‐Shapceska.
Developing probiotic pumpkin juice by fermentation with commercial probiotic strain
Lactobacillus casei
431
. Journal of Food Processing and Preservation 2021; 45(3) doi: 10.1111/jfpp.15245
|
9 |
T. Ewais, J. Begun, M. Kenny, K. Hay, Evan Houldin, Kai-Hisang Chuang, M. Tefay, S. Kisely. Mindfulness based cognitive therapy for youth with inflammatory bowel disease and depression - Findings from a pilot randomised controlled trial. Journal of Psychosomatic Research 2021; 149: 110594 doi: 10.1016/j.jpsychores.2021.110594
|
10 |
Elena Layunta, Berta Buey, Jose Emilio Mesonero, Eva Latorre. Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.748254
|
11 |
Yihan Zhuang, Hairu Yang, Xinyi Huang, Guanghua Guo, Quan Shi, Yiting Lin, Wenwen Xue, Zeyu Huang, Sisi Zhou, Jiahui Cai, Haizhu Tan, Jing Yu. Unique quantitative electroencephalography differences and related behavioral dynamics in Crohn’s disease. All Life 2024; 17(1) doi: 10.1080/26895293.2024.2422994
|
12 |
Davide Banfi, Elisabetta Moro, Annalisa Bosi, Michela Bistoletti, Silvia Cerantola, Francesca Crema, Fabrizio Maggi, Maria Cecilia Giron, Cristina Giaroni, Andreina Baj. Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2021; 22(4): 1623 doi: 10.3390/ijms22041623
|
13 |
Xiang Lu, Zhengyang Xue, Yu Qian, Shanjie Wei, Yu Qiao, Wen Zhang, Hongyan Lu. Changes in intestinal microflora and its metabolites underlie the cognitive impairment in preterm rats. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.945851
|
14 |
Piplu Bhuiyan, Yinan Chen, Mazharul Karim, Hongquan Dong, Yanning Qian. Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention. Brain Research Bulletin 2021; 172: 61 doi: 10.1016/j.brainresbull.2021.04.010
|
15 |
Piplu Bhuiyan, Yi-Wei Wang, Huan-Huan Sha, Hong-Quan Dong, Yan-Ning Qian. Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases. Neural Regeneration Research 2021; 16(11): 2184 doi: 10.4103/1673-5374.310608
|
16 |
Anna Onisiforou, George M Spyrou. Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches. Briefings in Bioinformatics 2021; 22(6) doi: 10.1093/bib/bbab141
|
17 |
Sisi Zhou, Jing Yu. Crohn’s disease and breast cancer: a literature review of the mechanisms and treatment. Internal and Emergency Medicine 2023; 18(5): 1303 doi: 10.1007/s11739-023-03281-0
|
18 |
Mahmoud Khatib A.A. Al-Ruweidi, Nada Khater, Haya Rashid Alkaabi, Maram Hasan, Huseyin C. Yalcin. Immunology of the GI Tract - Recent Advances. 2022; doi: 10.5772/intechopen.106184
|
19 |
Piero Sciavilla, Francesco Strati, Monica Di Paola, Monica Modesto, Francesco Vitali, Duccio Cavalieri, Gian Maria Prati, Maura Di Vito, Giovanni Aragona, Carlotta De Filippo, Paola Mattarelli. Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients. Applied Microbiology and Biotechnology 2021; 105(8): 3277 doi: 10.1007/s00253-021-11264-4
|
20 |
Parmjit Singh Panesar, Anil Kumar Anal, Rupinder Kaur. Probiotics, Prebiotics and Synbiotics. 2022; : 1 doi: 10.1002/9781119702160.ch1
|
21 |
Anjalee Bhratee, Mayank Kumar, Md Reyaz Alam, Piyush Anand, Shamsher Singh. Understanding Alzheimer’s Disease by Targeting Gut Microbiota and Role of Heavy Metals: Insight from Novel Therapeutical Approach. Current Pharmacology Reports 2023; 9(4): 177 doi: 10.1007/s40495-023-00325-z
|
22 |
Belén Carro. SARS-CoV-2 mechanisms of action and impact on human organism, risk factors and potential treatments. An exhaustive survey. All Life 2021; 14(1): 894 doi: 10.1080/26895293.2021.1977186
|
23 |
Lie Zheng, Xin-Li Wen. Gut microbiota and inflammatory bowel disease: The current status and perspectives. World Journal of Clinical Cases 2021; 9(2): 321-333 doi: 10.12998/wjcc.v9.i2.321
|
24 |
Francesco Vito Mandarino, Emanuele Sinagra, Dario Raimondo, Silvio Danese. The Role of Microbiota in Upper and Lower Gastrointestinal Functional Disorders. Microorganisms 2023; 11(4): 980 doi: 10.3390/microorganisms11040980
|
25 |
Simona Porru, Ana Esplugues, Sabrina Llop, Juana María Delgado-Saborit. The effects of heavy metal exposure on brain and gut microbiota: A systematic review of animal studies. Environmental Pollution 2024; 348: 123732 doi: 10.1016/j.envpol.2024.123732
|
26 |
Claudio Fiocchi, Gabriele Dragoni, Dimitrios Iliopoulos, Konstantinos Katsanos, Vicent Hernandez Ramirez, Kohei Suzuki, Bram Verstockt, Claudio Fiocchi, Joana Torres, Michael Scharl. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—What, Why, and How. Journal of Crohn's and Colitis 2021; 15(9): 1410 doi: 10.1093/ecco-jcc/jjab051
|
27 |
Cecilia Binda, Giulia Gibiino, Chiara Coluccio, Monica Sbrancia, Elton Dajti, Emanuele Sinagra, Gabriele Capurso, Vittorio Sambri, Alessandro Cucchetti, Giorgio Ercolani, Carlo Fabbri. Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases. Microorganisms 2022; 10(2): 312 doi: 10.3390/microorganisms10020312
|
28 |
Angela Saviano, Gunawardena Gayani, Alessio Migneco, Marcello Candelli, Francesco Franceschi, Veronica Ojetti, Christian Zanza, Yaroslava Longhitano. The Gut Microbiota-Brain Axis in Acute Neurological Disease: Focus on
Stroke. Reviews on Recent Clinical Trials 2022; 17(4): 240 doi: 10.2174/1574887117666220321155508
|
29 |
Emanuele Sinagra, Gaia Pellegatta, Valentina Guarnotta, Marcello Maida, Francesca Rossi, Giuseppe Conoscenti, Socrate Pallio, Rita Alloro, Dario Raimondo, Fabio Pace, Andrea Anderloni. Microbiota Gut–Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease. Life 2021; 11(7): 715 doi: 10.3390/life11070715
|
30 |
Anna Atlante, Giuseppina Amadoro, Antonella Bobba, Valentina Latina. Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease. Cells 2020; 9(11): 2347 doi: 10.3390/cells9112347
|
31 |
Oshin Miranda, Peihao Fan, Xiguang Qi, Zeshui Yu, Jian Ying, Haohan Wang, David A. Brent, Jonathan C. Silverstein, Yu Chen, Lirong Wang. DeepBiomarker: Identifying Important Lab Tests from Electronic Medical Records for the Prediction of Suicide-Related Events among PTSD Patients. Journal of Personalized Medicine 2022; 12(4): 524 doi: 10.3390/jpm12040524
|
32 |
Kimina Lyall, George Youssef, Antonina Mikocka-Walus, Subhadra Evans, Robert A. Cummins. Exploring Evidence for Mindfulness and Subjective Wellbeing Homeostatic Resilience Buffering Depression and Stress Symptoms Associated with Inflammatory Bowel Disease. Journal of Happiness Studies 2023; 24(5): 1663 doi: 10.1007/s10902-023-00632-8
|
33 |
Xianglu Ye, Miao Zhang, Ning Zhang, Hai Wei, Bing Wang. Gut-brain axis interacts with immunomodulation in inflammatory bowel disease. Biochemical Pharmacology 2024; 219: 115949 doi: 10.1016/j.bcp.2023.115949
|
34 |
Sunil Kumar, Awanish Kumar. Microbial pathogenesis in inflammatory bowel diseases. Microbial Pathogenesis 2022; 163: 105383 doi: 10.1016/j.micpath.2021.105383
|
35 |
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Bakhadir S. Azizov, Vadim Samusenkov, Walid Kamal Abdelbasset, Ghulam Yasin, Hawraa Jabbar Mohammad, Mohammed Abed Jawad, Trias Mahmudiono, Seyed Reza Hosseini‐Fard, Rasoul Mirzaei, Sajad Karampoor. The emerging microbiome‐based approaches to IBD therapy: From SCFAs to urolithin A. Journal of Digestive Diseases 2022; 23(8-9): 412 doi: 10.1111/1751-2980.13131
|